Lymphotoxin-dependent Control of Innate Immune Responses in the Gut

Alexei Tumanov,Ekaterina Koroleva,Yang-Xin Fu

DOI: https://doi.org/10.1097/00054725-201112002-00031

2011-01-01

Inflammatory Bowel Diseases

Abstract:Innate lymphoid cells (ILCs) represent a heterogeneous population that regulates the balance between protective immunity and immunopathology in the gut. However, the pathways that mediate crosstalk between ILCs, dendritic cells and intestinal epithelial cells in response to mucosal bacterial infection remain poorly understood. Citrobacter rodentium (C. rodentium) is a natural mouse pathogen that represents a model of human infectious colitis caused by pathogenic E. coli. IL-22 is required for gut protection by enhancing barrier integrity and epithelial innate immunity. We found that Lymphotoxin (LT), a member of TNF superfamily of cytokines, is critical for IL-22 production by RORγt+ ILCs cells in the gut after C. rodentium infection, while expression of LT by adaptive T and B cells was dispensable for IL-22 production and mice protection. We found that LTi cells, but not NKp46+ cells were the major IL-22 producing cells in the colon lamina propria after infection. Surprisingly, IL-22 producing LTi cells were predominantly located in lymphoid follicles in the colon, and interacted closely with DCs. LT expression by LTi cells was essential for the development of lymphoid follicles in the gut. Furthermore, stimulation of LTβR signalling with agonistic antibody promoted IL-22 production and lymphoid follicles formation after infection. By using a conditional gene targeting approach, we demonstrate that a LT-driven positive feedback loop controls IL-22 production by RORγt+ LTi cells via LTβR signaling in DCs. Thus, our data suggest that LTβR signaling regulates IL-22 production by ILCs in the gut and that pharmacological manipulation of LTγR signaling could be used to control inflammatory responses in the gut.